NeoGenomics Inc (NEO) stock
NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3023% below fair value
$15.29+0.04 (+0.26%)
Close on Nov 18, 2026Market cap $1.98BP/E –Yield –
NeoGenomics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
NeoGenomics's pe ratio was 66.3× on Jan 31, 2022, against 361.8× a year earlier. Over the last 5 years it ranged from 66.3× to 889.7×, with a median of 226.5×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Jan 31, 2022 | 66.3× | −34.1 |
| 2021 | Dec 31, 2021 | 100.3× | −789.3 |
| 2020 | May 29, 2020 | 889.7× | +483.5 |
| 2019 | Jul 31, 2019 | 406.2× | +248.5 |
| 2018 | Dec 31, 2018 | 157.6× | −524.4 |
| 2016 | Jan 29, 2016 | 682.0× | −105.0 |
| 2015 | Dec 31, 2015 | 787.0× | +578.5 |
| 2014 | Dec 31, 2014 | 208.5× | +87.8 |
| 2013 | Dec 31, 2013 | 120.7× | −218.5 |
| 2012 | Dec 31, 2012 | 339.2× | – |
See a number that looks wrong?